Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03449888 · ClinicalTrials.gov registry record
Arm Exercise Versus Pharmacologic Stress Testing for Clinical Outcome
A clinical trial, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- 133
- Enrollment target
NCT03449888: Clinical Trial study, sponsored by VA Office of Research and Development.
NCT03449888 is a clinical trial that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 133 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03449888 was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- 133 participants
- Enrollment target
Study Summary
This is a 5-year clinical trial to evaluate whether arm exercise electrocardiographic (ECG) stress testing without or with coronary artery calcium scoring (-/+ CAC) is non-inferior to treadmill ECG stress testing -/+ CAC and pharmacologic myocardial perfusion imaging as an initial evaluation to detect obstructive coronary artery disease, determined by cardiac computed tomographic angiography (CTA) and to predict clinical outcome, defined by a primary clinical endpoint of the composite of cardiovascular (CV) mortality, myocardial infarction, and 90-day post-stress test coronary artery revascularization and secondary clinical endpoints of all-cause mortality and CV mortality.
Interventions
- PROCEDURE Regadenoson myocardial perfusion imaging stress test
- PROCEDURE Arm exercise electrocardiographic stress test
- PROCEDURE Treadmill electrocardiographic stress test
- PROCEDURE Coronary artery calcium score and cardiac computed tomographic angiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2021-02-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03449888
The ClinicalTrials.gov registry entry for NCT03449888 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Regadenoson myocardial perfusion imaging stress test is the first listed.
NCT03449888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03449888 about?
NCT03449888 is a clinical study titled "Arm Exercise Versus Pharmacologic Stress Testing for Clinical Outcome". This is a 5-year clinical trial to evaluate whether arm exercise electrocardiographic (ECG) stress testing without or with coronary artery calcium scoring (-/+ CAC) is non-inferior to treadmill ECG stress testing -/+ CAC and pharmacologic myocardial perfusion imaging as an initial evaluation to dete...
What is the current status of trial NCT03449888?
This trial is currently terminated. The enrollment target is 133 participants. The study started on 2018-07-01. Estimated completion is 2021-02-05.
What interventions are being tested in trial NCT03449888?
The interventions under investigation include: Regadenoson myocardial perfusion imaging stress test (PROCEDURE), Arm exercise electrocardiographic stress test (PROCEDURE), Treadmill electrocardiographic stress test (PROCEDURE), Coronary artery calcium score and cardiac computed tomographic angiography (PROCEDURE).
Who is sponsoring clinical trial NCT03449888?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.